chr20-13534052-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2
The NM_017714.3(TASP1):c.765G>A(p.Leu255=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00372 in 1,613,410 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0032 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 35 hom. )
Consequence
TASP1
NM_017714.3 synonymous
NM_017714.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.04
Genes affected
TASP1 (HGNC:15859): (taspase 1) This gene encodes an endopeptidase that cleaves specific substrates following aspartate residues. The encoded protein undergoes posttranslational autoproteolytic processing to generate alpha and beta subunits, which reassemble into the active alpha2-beta2 heterotetramer. It is required to cleave MLL, a protein required for the maintenance of HOX gene expression, and TFIIA, a basal transcription factor. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 20-13534052-C-T is Benign according to our data. Variant chr20-13534052-C-T is described in ClinVar as [Benign]. Clinvar id is 3033137.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=1.04 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00377 (5502/1461220) while in subpopulation AMR AF= 0.0195 (873/44662). AF 95% confidence interval is 0.0185. There are 35 homozygotes in gnomad4_exome. There are 2730 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TASP1 | NM_017714.3 | c.765G>A | p.Leu255= | synonymous_variant | 9/14 | ENST00000337743.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TASP1 | ENST00000337743.9 | c.765G>A | p.Leu255= | synonymous_variant | 9/14 | 1 | NM_017714.3 | P1 | |
TASP1 | ENST00000455532.5 | c.696G>A | p.Leu232= | synonymous_variant | 8/10 | 5 | |||
TASP1 | ENST00000465381.5 | n.662G>A | non_coding_transcript_exon_variant | 7/10 | 5 | ||||
TASP1 | ENST00000480436.5 | n.849G>A | non_coding_transcript_exon_variant | 9/14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00324 AC: 492AN: 152072Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
492
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00607 AC: 1522AN: 250782Hom.: 16 AF XY: 0.00535 AC XY: 725AN XY: 135502
GnomAD3 exomes
AF:
AC:
1522
AN:
250782
Hom.:
AF XY:
AC XY:
725
AN XY:
135502
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00377 AC: 5502AN: 1461220Hom.: 35 Cov.: 30 AF XY: 0.00376 AC XY: 2730AN XY: 726918
GnomAD4 exome
AF:
AC:
5502
AN:
1461220
Hom.:
Cov.:
30
AF XY:
AC XY:
2730
AN XY:
726918
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00324 AC: 493AN: 152190Hom.: 2 Cov.: 32 AF XY: 0.00348 AC XY: 259AN XY: 74396
GnomAD4 genome
AF:
AC:
493
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
259
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
58
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TASP1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at